Inactive Instrument

Carmat Share Price Other OTC

Medical Equipment, Supplies & Distribution

Analysts' recommendations: Carmat

09/05/25	Carmat: Invest Securities raises target price
11/04/25	Carmat: Invest Securities still a buyer, but cuts TP
04/02/25	Carmat: Invest Securities slightly lowers its target
09/01/25	Carmat: Invest Securities upgrades to buy
09/01/25	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat

03-04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
01-07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
01-07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
01-07	CARMAT : A suivre aujourd'hui
01-07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	31/08/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	11/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	31/03/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	01/01/2017
Michael Mack BRD	Director/Board Member	79	19/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	6.15M 7.03M 5.65M 5.26M 9.99M 669M 10.14M 67.8M 26.36M 329M 26.39M 25.82M 1.13B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 67.77M 54.45M 50.75M 96.26M 6.45B 97.72M 654M 254M 3.17B 254M 249M 10.93B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01-07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
01-07	CARMAT: To Watch Today
01-06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
01-06	Carmat Announces Liquidation and Delisting
12-02	Only Takeover Bid for Carmat Approved by Court
12-02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
12-02	Carmat receives takeover bid	RE
11-04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/10/25	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/10/25	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/10/25	Carmat says liquidation review postponed until Nov 25	RE
01/10/25	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
01/10/25	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

12-02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
11-04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/10/25	CARMAT : Inside Information / Other news releases	PU
29/10/25	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/10/25	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	7.08M
STRYKER CORPORATION	+4.20%	-1.85%	-17.39%	+9.58%	125B
SMITH & NEPHEW PLC	+0.04%	-1.01%	+1.39%	-6.08%	12.77B
GLAUKOS CORPORATION	+7.83%	+2.71%	+43.32%	+112.86%	8.71B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.29%	+7.17%	-46.92%	-72.29%	4.07B
DOUBLE MEDICAL TECHNOLOGY INC.	+4.16%	+8.39%	+25.37%	+43.89%	2.73B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+2.53%	+23.07%	-7.66%	-13.04%	1.89B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+3.55%	+8.85%	-0.99%	-23.29%	1.67B
L&C BIO CO.,LTD	-5.25%	-5.89%	+179.33%	+133.76%	1.46B
Average	+2.15%	+1.23%	+22.06%	+23.17%	19.81B
Weighted average by Cap.	+3.90%	+2.90%	-10.46%	+13.01%

	2023	2024
Net sales	3.84M 4.39M 3.53M 3.29M 6.23M 418M 6.33M 42.33M 16.46M 205M 16.48M 16.12M 708M	7.34M 8.4M 6.75M 6.29M 11.93M 800M 12.11M 81.02M 31.5M 393M 31.53M 30.86M 1.35B
Net income	-53.87M -61.62M -49.51M -46.14M -87.52M -5.87B -88.85M -594M -231M -2.88B -231M -226M -9.94B	-51.4M -58.79M -47.23M -44.03M -83.5M -5.6B -84.77M -567M -220M -2.75B -221M -216M -9.48B
Net Debt	49.64M 56.78M 45.62M 42.52M 80.65M 5.41B 81.87M 548M 213M 2.66B 213M 209M 9.16B	53.1M 60.74M 48.8M 45.49M 86.27M 5.78B 87.58M 586M 228M 2.84B 228M 223M 9.8B

Carmat Share Price Other OTC

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Carmat

Latest news : Carmat

Analysts' recommendations: Carmat

Press Releases: Carmat

News in other languages: Carmat

Managers and Directors: Carmat

Medical Devices & Implants

Financials

Company Profile